Hypera (OTCMKTS:HYPMY) Share Price Crosses Above 50-Day Moving Average - Here's What Happened

Shares of Hypera S.A. (OTCMKTS:HYPMY - Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $3.50 and traded as high as $3.80. Hypera shares last traded at $3.80, with a volume of 249 shares changing hands.

Hypera Stock Up 3.3 %

The firm's fifty day moving average is $3.53 and its 200 day moving average is $3.39. The firm has a market cap of $2.49 billion, a P/E ratio of 16.35 and a beta of 0.76. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.41 and a current ratio of 1.81.

Hypera (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.04) EPS for the quarter. The company had revenue of $184.34 million for the quarter. Hypera had a return on equity of 13.18% and a net margin of 20.04%.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.